Latest news with #Data#3Limited
Business Insider
4 days ago
- Business
- Business Insider
Data#3 Limited. (DTL) Gets a Buy from Macquarie
In a report released today, from Macquarie maintained a Buy rating on Data#3 Limited., with a price target of A$9.00. The company's shares opened today at A$7.65. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. In addition to Macquarie, Data#3 Limited. also received a Buy from Morgan Stanley's Chenny Wang in a report issued on August 1. However, on August 2, TR | OpenAI – 4o reiterated a Hold rating on Data#3 Limited. (ASX: DTL). Based on Data#3 Limited.'s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of A$391.18 million and a net profit of A$22.35 million. In comparison, last year the company earned a revenue of A$443.55 million and had a net profit of A$21.42 million
Yahoo
14-04-2025
- Business
- Yahoo
Retail investors who hold 60% of Data#3 Limited (ASX:DTL) gained 7.9%, institutions profited as well
The considerable ownership by retail investors in Data#3 indicates that they collectively have a greater say in management and business strategy A total of 25 investors have a majority stake in the company with 37% ownership Recent sales by insiders We've discovered 2 warning signs about Data#3. View them for free. To get a sense of who is truly in control of Data#3 Limited (ASX:DTL), it is important to understand the ownership structure of the business. We can see that retail investors own the lion's share in the company with 60% ownership. Put another way, the group faces the maximum upside potential (or downside risk). Following a 7.9% increase in the stock price last week, retail investors profited the most, but institutions who own 31% stock also stood to gain from the increase. In the chart below, we zoom in on the different ownership groups of Data#3. See our latest analysis for Data#3 Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices. As you can see, institutional investors have a fair amount of stake in Data#3. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Data#3's earnings history below. Of course, the future is what really matters. Hedge funds don't have many shares in Data#3. Our data shows that State Street Global Advisors, Inc. is the largest shareholder with 5.4% of shares outstanding. The Vanguard Group, Inc. is the second largest shareholder owning 5.0% of common stock, and First Sentier Investors (Australia) IM Ltd holds about 3.2% of the company stock. On studying our ownership data, we found that 25 of the top shareholders collectively own less than 50% of the share register, implying that no single individual has a majority interest. While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future. The definition of an insider can differ slightly between different countries, but members of the board of directors always count. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves. Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances. Our most recent data indicates that insiders own some shares in Data#3 Limited. As individuals, the insiders collectively own AU$38m worth of the AU$1.1b company. Some would say this shows alignment of interests between shareholders and the board. But it might be worth checking if those insiders have been selling. The general public, who are usually individual investors, hold a substantial 60% stake in Data#3, suggesting it is a fairly popular stock. With this amount of ownership, retail investors can collectively play a role in decisions that affect shareholder returns, such as dividend policies and the appointment of directors. They can also exercise the power to vote on acquisitions or mergers that may not improve profitability. It seems that Private Companies own 6.1%, of the Data#3 stock. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company. It's always worth thinking about the different groups who own shares in a company. But to understand Data#3 better, we need to consider many other factors. For instance, we've identified 2 warning signs for Data#3 that you should be aware of. If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts. NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
24-03-2025
- Business
- Yahoo
Exploring Audinate Group And 2 Emerging Australian High Growth Tech Stocks
The Australian market recently saw the ASX200 close flat at 7,936 points with mixed performance across sectors, as Discretionary and Financials led gains while Information Technology lagged behind. In this environment of fluctuating sector performance, identifying high growth tech stocks like Audinate Group and other emerging players in Australia involves looking for companies that demonstrate resilience and innovation amidst broader market challenges. Name Revenue Growth Earnings Growth Growth Rating Clinuvel Pharmaceuticals 23.05% 25.80% ★★★★★☆ Gratifii 42.14% 113.99% ★★★★★★ Telix Pharmaceuticals 20.02% 34.26% ★★★★★★ Pro Medicus 23.02% 24.25% ★★★★★★ WiseTech Global 20.48% 25.55% ★★★★★★ Wrkr 51.62% 116.83% ★★★★★★ AVA Risk Group 29.15% 108.15% ★★★★★★ BlinkLab 65.54% 64.35% ★★★★★★ SiteMinder 21.09% 65.36% ★★★★★★ Opthea 59.34% 68.40% ★★★★★★ Click here to see the full list of 51 stocks from our ASX High Growth Tech and AI Stocks screener. Let's uncover some gems from our specialized screener. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Audinate Group Limited specializes in developing and selling digital audio visual networking solutions both in Australia and internationally, with a market capitalization of A$542.66 million. Operations: The company generates revenue primarily through its Contract Electronics Manufacturing Services, which amounted to A$73.60 million. Despite recent challenges, including a drop from the S&P/ASX 200 Index and a significant earnings decline in the latest half-year results, Audinate Group demonstrates resilience with its strategic focus on innovation. The company's commitment to R&D is evident as it navigates through a tough phase marked by a sales decrease to AUD 28.72 million from AUD 46.6 million year-over-year and swinging to a net loss of AUD 2.21 million from a prior net income of AUD 4.75 million. However, looking forward, Audinate is poised for recovery with anticipated revenue growth at an annual rate of 16.1%, outpacing the Australian market's average of 5.9%. This growth trajectory coupled with an expected earnings increase of approximately 50.7% annually suggests potential for rebound as market conditions improve. Navigate through the intricacies of Audinate Group with our comprehensive health report here. Understand Audinate Group's track record by examining our Past report. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Data#3 Limited is an IT solutions and services provider operating in Australia, Fiji, and the Pacific Islands with a market capitalization of A$1.16 billion. Operations: The company generates revenue primarily through its Value-Added IT Reseller and IT Solutions Provider segment, which accounts for A$798.05 million. The business focuses on delivering comprehensive IT solutions and services across multiple regions, contributing to its financial performance. Data#3 Limited, a contender in Australia's tech landscape, shows promising financial dynamics despite a slight dip in sales to AUD 391.18 million from AUD 398.88 million year-over-year. The company's net income also saw a decrease, settling at AUD 22.35 million compared to the previous year's AUD 30.76 million. However, its commitment to innovation and growth is clear with an expected revenue increase of 23.9% annually and earnings projected to rise by 10.7% per year, outstripping the Australian market average growth rates of 5.9% and 12.2%, respectively. This performance is bolstered by strategic leadership changes and consistent dividend payouts, signaling robust governance and shareholder value focus amidst evolving market conditions. Take a closer look at Data#3's potential here in our health report. Gain insights into Data#3's historical performance by reviewing our past performance report. Simply Wall St Growth Rating: ★★★★★★ Overview: Pro Medicus Limited is a healthcare informatics company that develops and supplies healthcare imaging software and radiology information system software to hospitals, imaging centers, and healthcare groups across Australia, North America, and Europe with a market cap of A$24.02 billion. Operations: Pro Medicus generates revenue primarily through the production of integrated software applications for the healthcare industry, amounting to A$184.58 million. The company's focus on healthcare imaging and radiology information systems supports its operations across Australia, North America, and Europe. Pro Medicus, recently added to the S&P/ASX 50 Index, continues to demonstrate robust growth with a 23% annual revenue increase and a notable 24.3% rise in earnings per year, outpacing the Australian market's average. This performance is underpinned by significant R&D investment, which has fueled innovations driving these financial achievements. The company's strategic positioning in high-growth sectors, coupled with recent presentations at major industry events like the Morgan Stanley Technology Conference, underscores its commitment to maintaining a leading edge in tech development. With earnings growing by 41% over the past year and forecasted substantial growth over the next three years, Pro Medicus appears well-positioned to sustain its upward trajectory amidst dynamic market conditions. Dive into the specifics of Pro Medicus here with our thorough health report. Review our historical performance report to gain insights into Pro Medicus''s past performance. Explore the 51 names from our ASX High Growth Tech and AI Stocks screener here. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:AD8 ASX:DTL and ASX:PME. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
08-03-2025
- Business
- Yahoo
Data#3's (ASX:DTL) Dividend Will Be Increased To A$0.131
Data#3 Limited (ASX:DTL) has announced that it will be increasing its periodic dividend on the 31st of March to A$0.131, which will be 4.0% higher than last year's comparable payment amount of A$0.126. This will take the dividend yield to an attractive 3.4%, providing a nice boost to shareholder returns. Check out our latest analysis for Data#3 While it is great to have a strong dividend yield, we should also consider whether the payment is sustainable. The last payment made up 91% of earnings, but cash flows were much higher. Since the dividend is just paying out cash to shareholders, we care more about the cash payout ratio from which we can see plenty is being left over for reinvestment in the business. The next year is set to see EPS grow by 41.7%. Assuming the dividend continues along the course it has been charting recently, our estimates show the payout ratio being 74% which brings it into quite a comfortable range. While the company has been paying a dividend for a long time, it has cut the dividend at least once in the last 10 years. Since 2015, the dividend has gone from A$0.045 total annually to A$0.262. This means that it has been growing its distributions at 19% per annum over that time. Despite the rapid growth in the dividend over the past number of years, we have seen the payments go down the past as well, so that makes us cautious. Given that the dividend has been cut in the past, we need to check if earnings are growing and if that might lead to stronger dividends in the future. It's encouraging to see that Data#3 has been growing its earnings per share at 16% a year over the past five years. Recently, the company has been able to grow earnings at a decent rate, but with the payout ratio on the higher end we don't think the dividend has many prospects for growth. Overall, we always like to see the dividend being raised, but we don't think Data#3 will make a great income stock. The company is generating plenty of cash, which could maintain the dividend for a while, but the track record hasn't been great. We would probably look elsewhere for an income investment. Companies possessing a stable dividend policy will likely enjoy greater investor interest than those suffering from a more inconsistent approach. Still, investors need to consider a host of other factors, apart from dividend payments, when analysing a company. As an example, we've identified 1 warning sign for Data#3 that you should be aware of before investing. If you are a dividend investor, you might also want to look at our curated list of high yield dividend stocks. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
20-02-2025
- Business
- Yahoo
3 High Growth Tech Stocks in Australia
As the Australian market grapples with a 0.49% decline in ASX 200 futures and mixed signals from global economic events, investors are keenly watching for opportunities in high-growth sectors like technology, especially as U.S. indices like the S&P 500 reach new highs. In this context, identifying promising tech stocks involves assessing their resilience to broader market fluctuations and their ability to capitalize on emerging trends within the industry. Name Revenue Growth Earnings Growth Growth Rating Clinuvel Pharmaceuticals 21.39% 26.17% ★★★★★★ Pureprofile 14.31% 71.53% ★★★★★☆ Adherium 86.80% 73.66% ★★★★★★ Pro Medicus 22.46% 23.62% ★★★★★★ Gratifii 40.96% 103.72% ★★★★★★ AVA Risk Group 25.54% 77.32% ★★★★★★ Mesoblast 49.04% 54.89% ★★★★★★ Pointerra 56.62% 126.45% ★★★★★★ Wrkr 44.16% 98.46% ★★★★★★ Opthea 51.59% 60.35% ★★★★★★ Click here to see the full list of 51 stocks from our ASX High Growth Tech and AI Stocks screener. Underneath we present a selection of stocks filtered out by our screen. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Data#3 Limited provides IT solutions and services across Australia, Fiji, and the Pacific Islands with a market capitalization of A$1.24 billion. Operations: Data#3 Limited focuses on delivering a range of IT solutions and services across multiple regions, including Australia, Fiji, and the Pacific Islands. The company operates with a market capitalization of approximately A$1.24 billion. Data#3, a player in Australia's tech landscape, is navigating a competitive market with its significant annual revenue growth of 36.9%, outpacing the Australian market average of 6%. Despite this robust top-line expansion, earnings growth at 10.6% annually lags slightly behind the broader market's 11.4%. The company's recent financials show a dip in net income to AUD 22.35 million from AUD 30.76 million year-over-year, suggesting some challenges in profitability amidst its revenue surge. Adding strategic depth, the appointment of Bronwyn Morris to the board could enhance governance and risk management as Data#3 continues to scale operations within high-growth sectors. Unlock comprehensive insights into our analysis of Data#3 stock in this health report. Gain insights into Data#3's historical performance by reviewing our past performance report. Simply Wall St Growth Rating: ★★★★★★ Overview: Pro Medicus Limited is a healthcare informatics company that develops and supplies imaging software and radiology information system services to hospitals, imaging centers, and healthcare groups across Australia, North America, and Europe with a market cap of A$31.05 billion. Operations: The company generates revenue primarily from producing integrated software applications for the healthcare industry, amounting to A$184.58 million. It focuses on providing imaging and radiology information system software and services to a global clientele, including hospitals and imaging centers in key regions such as Australia, North America, and Europe. Pro Medicus, a standout in Australia's tech sector, showcased remarkable financial performance with half-year sales jumping from AUD 74.11 million to AUD 97.19 million and net income soaring by over 42% to AUD 51.75 million. This surge is supported by an aggressive R&D focus, crucial for maintaining its edge in healthcare technology innovations. The company also increased its interim dividend significantly, reflecting strong cash reserves and confidence in sustained growth, underpinned by a robust annual revenue growth forecast of 22.5%. These strategic moves position Pro Medicus well within a competitive landscape where technological advancement is paramount. Dive into the specifics of Pro Medicus here with our thorough health report. Explore historical data to track Pro Medicus' performance over time in our Past section. Simply Wall St Growth Rating: ★★★★☆☆ Overview: SEEK Limited operates as an online employment marketplace service provider across Australia, South East Asia, New Zealand, the United Kingdom, Europe, and other international regions with a market capitalization of approximately A$9.30 billion. Operations: SEEK Limited generates revenue primarily through its online employment marketplace services, with significant contributions from the ANZ region at A$821.40 million and Asia at A$240.90 million. Amidst a challenging fiscal landscape, SEEK Limited has demonstrated resilience with its recent financial outcomes, notably a net income leap to AUD 143.5 million from AUD 29.8 million in the previous year. This robust performance is underpinned by an aggressive R&D strategy that aligns with its revenue forecast growth of 9.1% annually, surpassing the Australian market average of 6%. Moreover, the company's commitment to shareholder returns is evident from its increased interim dividend of 24 cents per share, up by 26%, showcasing confidence in future profitability and cash flow stability. These strategic initiatives reflect SEEK's adaptability and potential for sustained growth within the dynamic tech sector in Australia. Get an in-depth perspective on SEEK's performance by reading our health report here. Evaluate SEEK's historical performance by accessing our past performance report. Dive into all 51 of the ASX High Growth Tech and AI Stocks we have identified here. Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports. Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:DTL ASX:PME and ASX:SEK. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
